Innate Immunotherapeutics announces Results of Annual General Meeting
Innate Immunotherapeutics Limited (ASX Code: IIL) is pleased to confirm that each of the resolutions considered at its Annual General Meeting held earlier today were passed. Details of the proxies received and the poll results in respect of resolutions 15-19 are annexed hereto.
For further information, please download pdf attached:
Download this document
